1. Home
  2. RYDE vs CNSP Comparison

RYDE vs CNSP Comparison

Compare RYDE & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYDE
  • CNSP
  • Stock Information
  • Founded
  • RYDE 2014
  • CNSP 2017
  • Country
  • RYDE Singapore
  • CNSP United States
  • Employees
  • RYDE N/A
  • CNSP N/A
  • Industry
  • RYDE
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • RYDE
  • CNSP Health Care
  • Exchange
  • RYDE NYSE
  • CNSP Nasdaq
  • Market Cap
  • RYDE 5.2M
  • CNSP 5.6M
  • IPO Year
  • RYDE 2024
  • CNSP 2019
  • Fundamental
  • Price
  • RYDE $0.36
  • CNSP $0.86
  • Analyst Decision
  • RYDE
  • CNSP Hold
  • Analyst Count
  • RYDE 0
  • CNSP 1
  • Target Price
  • RYDE N/A
  • CNSP N/A
  • AVG Volume (30 Days)
  • RYDE 29.7M
  • CNSP 178.2K
  • Earning Date
  • RYDE 05-02-2025
  • CNSP 08-13-2025
  • Dividend Yield
  • RYDE N/A
  • CNSP N/A
  • EPS Growth
  • RYDE N/A
  • CNSP N/A
  • EPS
  • RYDE N/A
  • CNSP N/A
  • Revenue
  • RYDE $6,557,978.00
  • CNSP N/A
  • Revenue This Year
  • RYDE $21.13
  • CNSP N/A
  • Revenue Next Year
  • RYDE $13.43
  • CNSP N/A
  • P/E Ratio
  • RYDE N/A
  • CNSP N/A
  • Revenue Growth
  • RYDE 3.27
  • CNSP N/A
  • 52 Week Low
  • RYDE $0.16
  • CNSP $0.73
  • 52 Week High
  • RYDE $22.49
  • CNSP $82.50
  • Technical
  • Relative Strength Index (RSI)
  • RYDE N/A
  • CNSP 48.03
  • Support Level
  • RYDE N/A
  • CNSP $0.85
  • Resistance Level
  • RYDE N/A
  • CNSP $0.95
  • Average True Range (ATR)
  • RYDE 0.00
  • CNSP 0.08
  • MACD
  • RYDE 0.00
  • CNSP 0.02
  • Stochastic Oscillator
  • RYDE 0.00
  • CNSP 59.17

About RYDE RYDE GROUP LTD

Ryde Group Ltd operates a technology platform that provides a range of ride-hailing, carpooling and delivery focused offerings in Singapore. The company operates in twos segments namely Mobility provides on-demand and scheduled carpooling and ride-hailing services, matching riders to its driver partners; and Quick Commerce provides on-demand, scheduled, and multi-stop parcel delivery services.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: